InvestorsHub Logo
Followers 97
Posts 3675
Boards Moderated 0
Alias Born 11/13/2018

Re: Biobillionair post# 304292

Saturday, 10/10/2020 2:21:18 PM

Saturday, October 10, 2020 2:21:18 PM

Post# of 430335
EXACTLY, BB. EXACTLY. Beautifully stated. Markman's analysis is off. Plus the real Kurabayashi table being an "exhibit", among 2000 trial exhibits, does not save the generics, as it was the cropped table which appeared in their Proposed Findings of Fact, and it was the cropped table which appeared in Judge Du's Opinion. She did not copy the real table, she copied the cropped one.

Moreover, as explained in our Brief, the Therasense case, an en banc decision of the Federal Circuit, holds that when there is a situation of unclean hands/fraud on the court, one does not even have to prove materiality. What Markman did was just rattle off his perceptions based upon his understanding, without actually reading the Brief.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News